Yoshida et al. reported immunohistochemical findings for epiplakin in pancreatic ductal adenocarcinoma precursor lesions [23] and demonstrated that epiplakin was expressed in precancerous lesions but not in pancreatic cancer. This evidence concerns the gene EPPK1 and pancreatic neoplasm.